Health Canada proposes strict limits on marijuana packaging, production (cbc.ca)
National survey reveals new data on Canadian cannabis consumers? (straight.com)
Joint Ventures: How growers are trying to stand out in the cannabis crowd (cbc.ca)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Acute Pulmonary Physiologic Effects of Smoked Marijuana and Oral Δ9-Tetrahydrocannabinol in Healthy Young Men
The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders
Prenatal cannabis exposure - The “first hit” to the endocannabinoid system
Clinical Applications for Cannabis and Cannabinoids
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
An ultra-low dose of tetrahydrocannabinol provides cardioprotection.
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions
Cannabinoid WIN?55,212?2 mesylate inhibits ADAMTS?4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan?1.
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) in subcutaneous tissue and fasciae
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation
Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users
Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities?
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
CB2 receptors as new therapeutic targets for liver diseases
Cannabinoid receptors in acute and chronic complications of atherosclerosis.
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids?
GPR55: a new member of the cannabinoid receptor clan?
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
Allosterism and cannabinoid CB(1) receptors: the shape of things to come.
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.
The endocannabinoid system: a general view and latest additions.
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs